Xiaoyuan Han

Dr. Xiaoyuan Han

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 May 2021 in Science Translational Medicine
Verified
Journal Article
Closed access
ISIna A. Stelzer
Ina A. Stelzer
MGMohammad S. Ghaemi
Mohammad S. Ghaemi
XHXiaoyuan Han
Xiaoyuan Han
KAKazuo Ando
Kazuo Ando
JHJulien J. Hédou
Julien J. Hédou
BGBrice Gaudilliere
Brice Gaudilliere
Peripheral blood dynamics in the 100 days before delivery reveal a transition from pregnancy maintenance to prelabor biology.

12 October 2020 in Nature Machine Intelligence
Verified
Journal Article
Closed access
PDF file
ACAnthony Culos
Anthony Culos
ATAmy S. Tsai
Amy S. Tsai
NSNatalie Stanley
Natalie Stanley
MBMartin Becker
Martin Becker
MGMohammad S. Ghaemi
Mohammad S. Ghaemi
NANima Aghaeepour
Nima Aghaeepour

27 July 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
NSNatalie Stanley
Natalie Stanley
ISIna A. Stelzer
Ina A. Stelzer
ATAmy S. Tsai
Amy S. Tsai
RFRamin Fallahzadeh
Ramin Fallahzadeh
EGEdward Ganio
Edward Ganio
NANima Aghaeepour
Nima Aghaeepour
High-throughput single-cell analysis technologies produce an abundance of data that is critical for profiling the heterogeneity of cellular systems. We introduce VoPo (https://github.com/stanleyn/VoPo), a machine learning algorithm for predictive modeling and comprehensive visualization of the heterogeneity captured in large single-cell datasets. In three mass cytometry datasets, with the largest measuring hundreds of millions of cells over hundreds of samples, VoPo defines phenotypically and functionally homogeneous cell populations. VoPo further outperforms state-of-the-art machine learning algorithms in classification tasks, and identified immune-correlates of clinically-relevant parameters.

1 January 2022 in Clinical & Translational Immunology
Verified
Journal Article
Open access
HRHabib Sadeghi Rad
Habib Sadeghi Rad
YSYavar Shiravand
Yavar Shiravand
PRPayar Radfar
Payar Radfar
RLRahull Ladwa
Rahull Ladwa
CPChris Perry
Chris Perry
AKArutha Kulasinghe
Arutha Kulasinghe
Head and neck squamous cell carcinoma (HNSCC) represents a heterogeneous group of tumors. While significant progress has been made using multimodal treatment, the 5‐year survival remains at 50%. Developing effective therapies, such as immunotherapy, will likely lead to better treatment of primary and metastatic disease. However, not all HNSCC tumors respond to immune checkpoint blockade therapy. Understanding the complex cellular composition and interactions of the tumor microenvironment is likely to lead to new knowledge for effective therapies and treatment resistance. In this review, we discuss HNSCC characteristics, predictive biomarkers, factors influencing immunotherapy response, with a focus on the tumor microenvironment.

25 March 2022 in Plant Communications
Verified
Journal Article
Open access
BZBiaoming Zhang
Biaoming Zhang
XHXiaoyuan Han
Xiaoyuan Han
Wenya YuanWenya Yuan
Wenya Yuan
HZHaitao Zhang
Haitao Zhang
Xanthomonas species colonize many host plants and cause huge losses worldwide. Transcription activator-like effectors (TALEs) are secreted by Xanthomonas and translocated into host cells to manipulate the expression of target genes, especially by Xanthomonas oryzae pv. oryzae and Xanthomonas oryzae pv. oryzicola, which cause bacterial blight and bacterial leaf streak, respectively, in rice. In this review, we summarize the progress of studies on the interaction between Xanthomonas and hosts, covering both rice and other plants. TALEs are not only key factors that make plants susceptible but are also essential components of plant resistance. Characterization of TALEs and TALE-like proteins has improved our understanding of TALE evolution and promoted the development of gene editing tools. In addition, the interactions between TALEs and hosts have also provided strategies and possibilities for genetic engineering in crop improvement.

6 January 2025 in Oral
Verified
Journal Article
Open access
PDF file
ZXZander Xu
Zander Xu
ALAlice Lin
Alice Lin
XHXiaoyuan Han
Xiaoyuan Han
Artificial intelligence (AI), particularly through machine learning (ML) and deep learning (DL) techniques such as convolutional neural networks (CNNs) and natural language processing (NLP), has shown remarkable promise in image analysis and clinical documentation in oral pathology. In order to explore the transformative potential of artificial intelligence (AI) in oral pathology, this review highlights key studies demonstrating current AI’s improvement in oral pathology, such as detecting oral diseases accurately and streamlining diagnostic processes. However, several limitations, such as data quality, generalizability, legal and ethical considerations, financial constraints, and the need for paradigm shifts in practice, are critically examined. Addressing these challenges through collaborative efforts, robust validation, and strategic integration can pave the way for AI to revolutionize oral pathology, ultimately improving patient outcomes and advancing the field.